97 related articles for article (PubMed ID: 2845271)
21. [On the pathogenesis of vaccination damage in childhood].
Mahnke PF
Z Gesamte Inn Med; 1967 Dec; 22(24):806-11. PubMed ID: 5585477
[No Abstract] [Full Text] [Related]
22. Public health. Creeping consensus on SV40 and polio vaccine.
Ferber D
Science; 2002 Oct; 298(5594):725-7. PubMed ID: 12399560
[No Abstract] [Full Text] [Related]
23. [Convulsive syndrome following anti-poliomyelitis vaccination (Salk)].
Giovannucci M
Riv Sper Freniatr Med Leg Alien Ment; 1967 Oct; 91(5):1185-94. PubMed ID: 5608974
[No Abstract] [Full Text] [Related]
24. Contaminated polio vaccines. Will the next shot be fired in the courtroom?
Goldman MR; Brock MJ
J Leg Med; 1999 Jun; 20(2):223-49. PubMed ID: 10407618
[No Abstract] [Full Text] [Related]
25. [Hypsarrhythmia after triple vaccination].
Kringelbach J; Senstius J
Nord Med; 1966 Dec; 76(49):1433-6. PubMed ID: 4380915
[No Abstract] [Full Text] [Related]
26. SV40 bugaboo: spinning the news.
Kuska B
J Natl Cancer Inst; 1999 Apr; 91(8):662-4. PubMed ID: 10218499
[No Abstract] [Full Text] [Related]
27. Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines.
Laassri M; Lottenbach K; Belshe R; Rennels M; Plotkin S; Chumakov K
J Infect Dis; 2006 May; 193(10):1344-9. PubMed ID: 16619180
[TBL] [Abstract][Full Text] [Related]
28. [Antipeliemyelitie vaccination in pregnancy: research on immunologic tolerance].
De Flora S; Vannucci A
G Ig Med Prev; 1967; 8(4):477-92. PubMed ID: 5596429
[No Abstract] [Full Text] [Related]
29. [Atypical reactions after vaccination].
Dittman S
Beitr Hyg Epidemiol; 1981; 25():1-274. PubMed ID: 7020690
[No Abstract] [Full Text] [Related]
30. Vaccine-associated poliomyelitis cases.
Sabin AB
Bull World Health Organ; 1969; 40(6):947-9. PubMed ID: 5307605
[No Abstract] [Full Text] [Related]
31. Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines.
Hirvonen A; Mattson K; Karjalainen A; Ollikainen T; Tammilehto L; Hovi T; Vainio H; Pass HI; Di Resta I; Carbone M; Linnainmaa K
Mol Carcinog; 1999 Oct; 26(2):93-9. PubMed ID: 10506753
[TBL] [Abstract][Full Text] [Related]
32. [Vaccination complications (a case of vaccine-contact-poliomyelitis)].
Vogel C
Kinderarztl Prax; 1980 Jun; 48(6):296-9. PubMed ID: 7420869
[No Abstract] [Full Text] [Related]
33. Examination of poliovaccines for the presence of SV40 sequences.
Sangar DV; Wood DJ; Minor PD
Dev Biol Stand; 1998; 94():221-5. PubMed ID: 9776243
[TBL] [Abstract][Full Text] [Related]
34. [Dermatologic counterindications for protective vaccination in the GDR].
Dietz O
Z Arztl Fortbild (Jena); 1971 Aug; 65(15):803-6. PubMed ID: 4259138
[No Abstract] [Full Text] [Related]
35. Anaphylaxis due to vaccination in the office.
Ovens H
CMAJ; 1986 Feb; 134(4):369-70. PubMed ID: 3942946
[No Abstract] [Full Text] [Related]
36. Correspondence re: F. Martini et al., SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res., 56: 4820-4825, 1996.
Strickler H
Cancer Res; 1997 Aug; 57(15):3319-20. PubMed ID: 9242467
[No Abstract] [Full Text] [Related]
37. Safety of biopharmaceuticals: a current perspective.
Parkman PD
Dev Biol Stand; 1996; 88():5-7. PubMed ID: 9119163
[TBL] [Abstract][Full Text] [Related]
38. Anaphylaxis due to vaccination in the office.
CMAJ; 1986 May; 134(10):1109. PubMed ID: 3697848
[No Abstract] [Full Text] [Related]
39. [Uveitis, followed by amaurosis after vaccination against Heine-Medin disease in the course of labial herpes].
Janotka H
Klin Oczna; 1970; 40(3):407-9. PubMed ID: 5451385
[No Abstract] [Full Text] [Related]
40. [Considerations on the etiology of facial paralysis. I].
Ionescu N; Ciupe M; Sovrea D; Dimoftache E; Fogarassy F; Donogany A; Iuraşog G
Stud Cercet Inframicrobiol; 1968; 19(4):273-80. PubMed ID: 4304407
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
